{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T23:26:31Z","timestamp":1788218791228,"version":"build-2803163510"},"reference-count":109,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jceh.2022.07.246","type":"journal-article","created":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T21:17:16Z","timestamp":1659388636000},"page":"103-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Emerging Biomarkers in Alcohol-associated Hepatitis"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0009-8418","authenticated-orcid":false,"given":"Gene Y.","family":"Im","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2022.07.246_bib1","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.27779","article-title":"Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcohol-associated hepatitis","volume":"62","author":"Michelena","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.07.246_bib2","series-title":"Alcohol-associated Hepatitis","author":"Mendenhall","year":"1981"},{"key":"10.1016\/j.jceh.2022.07.246_bib3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.510250120","article-title":"Excess weight risk factor for alcohol-associated liver disease","volume":"25","author":"Naveau","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.07.246_bib4","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","article-title":"Standard definitions and common data elements for clinical trials in patients with alcohol-associated hepatitis: recommendation from the NIAAA Alcohol-associated Hepatitis Consortia","volume":"150","author":"Crabb","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.07.246_bib5","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1016\/S0168-8278(20)30852-7","article-title":"Non-invasive criteria for diagnosis of alcohol-associated hepatitis: use in clinical practice and correlation with prognosis","volume":"73","author":"Avitabile","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.07.246_bib6","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/acer.13108","article-title":"Diagnosis and treatment of alcohol-associated hepatitis: a systematic review","volume":"40","author":"Singal","year":"2016","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jceh.2022.07.246_bib7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.gastro.2015.05.015","article-title":"Gaps in knowledge and research priorities for alcohol-associated hepatitis","volume":"149","author":"Sanyal","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.07.246_bib8","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/ajg.2015.137","article-title":"PNPLA3 gene polymorphism is associated with predisposition to and severity of alcohol-associated liver disease","volume":"110","author":"Salameh","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.07.246_bib20","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.drugalcdep.2006.11.022","article-title":"Combinations of carbohydrate-deficient transferrin, mean corpuscular erythrocyte volume, gamma-glutamyltransferase, homocysteine and folate increase the significance of biological markers in alcohol dependent patients","volume":"89","author":"Rinck","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jceh.2022.07.246_bib21","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.cld.2012.08.001","article-title":"Prevalence and natural history of alcohol-associated liver disease","volume":"16","author":"Schwartz","year":"2012","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2022.07.246_bib22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/alcalc\/agh031","article-title":"Accuracy of carbohydrate-deficient transferrin in the detection of excessive alcohol consumption: a systematic review","volume":"39","author":"Koch","year":"2004","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.jceh.2022.07.246_bib23","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3109\/15622970109026807","article-title":"The activity of \u03b2-hexosaminidase (uHex) and \u03b3-glutamyl-transferase (uGGT) in urine as non-invasive markers of chronic alcohol abuse: I. Alcohol-dependent subjects","volume":"2","author":"Taracha","year":"2001","journal-title":"World J Biol Psychiatr"},{"key":"10.1016\/j.jceh.2022.07.246_bib24","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1592\/phco.28.6.769","article-title":"Ethylglucuronide as a biomarker for ethanol detection","volume":"28","author":"Kissack","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jceh.2022.07.246_bib25","doi-asserted-by":"crossref","first-page":"797","DOI":"10.15288\/jsad.2009.70.797","article-title":"Adolescent alcohol consumption: biomarkers PEth and FAEE in relation to interview and questionnaire data","volume":"70","author":"Comasco","year":"2009","journal-title":"J\u00a0Stud Alcohol Drugs"},{"key":"10.1016\/j.jceh.2022.07.246_bib26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hep.510260119","article-title":"Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcohol-associated steatohepatitis","volume":"26","author":"Grove","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.07.246_bib27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11481-009-9185-z","article-title":"Circulating cytokines as biomarkers of alcohol abuse and alcoholism","volume":"5","author":"Achur","year":"2010","journal-title":"J\u00a0Neuroimmune Pharmacol"},{"key":"10.1016\/j.jceh.2022.07.246_bib31","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.30866","article-title":"Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American association for the study of liver diseases","volume":"71","author":"Crabb","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.07.246_bib32","first-page":"1215","article-title":"Biological diagnosis of the type of liver disease in alcohol-associated patients with abnormal liver function tests","volume":"23","author":"Naveau","year":"1999","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.jceh.2022.07.246_bib33","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/apt.12427","article-title":"Determinants of long-term outcome in severe alcohol-associated hepatitis","volume":"38","author":"Potts","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2022.07.246_bib34","first-page":"161","article-title":"Clinical characteristics and outcomes of mild to moderate alcohol-associated hepatitis","volume":"1","author":"Samala","year":"2019","journal-title":"GastroHep"},{"key":"10.1016\/j.jceh.2022.07.246_bib35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/apt.15376","article-title":"Systematic review with meta-analysis: high mortality in patients with non-severe alcohol-associated hepatitis","volume":"50","author":"Bennett","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2022.07.246_bib36","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1016\/S0168-8278(20)30856-4","article-title":"Long-term outcome of symptomatic alcohol-associated hepatitis with a Maddrey discriminant function< 32","volume":"73","author":"Delphine","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.07.246_bib38","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jhep.2012.06.026","article-title":"Acute-on chronic liver failure","volume":"57","author":"Jalan","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.07.246_bib39","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.07.246_bib40","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jhep.2018.02.022","article-title":"The prognostic value of acute-on-chronic liver failure during the course of severe alcohol-associated hepatitis","volume":"69","author":"Serst\u00e9","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.07.246_bib41","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2014.06.012","article-title":"Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure","volume":"61","author":"Jalan","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.07.246_bib42","doi-asserted-by":"crossref","first-page":"399","DOI":"10.17235\/reed.2017.4701\/2016","article-title":"CLIF-C ACLF score is a better mortality predictor than MELD, MELD-Na and CTP in patients with Acute on chronic liver failure admitted to the ward","volume":"109","author":"Barosa","year":"2017","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.jceh.2022.07.246_bib43","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/gut.41.6.845","article-title":"Drinking habits as cofactors of risk for alcohol induced liver damage","volume":"41","author":"Bellentani","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2022.07.246_bib44","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1365-2265.2007.03125.x","article-title":"Induction of hepatic 11\u03b2-hydroxysteroid dehydrogenase type 1 in patients with alcohol-associated liver disease","volume":"68","author":"Ahmed","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jceh.2022.07.246_bib45","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1053\/j.gastro.2006.12.036","article-title":"Hepatic expression of candidate genes in patients with alcohol-associated hepatitis: correlation with disease severity","volume":"132","author":"Colmenero","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.07.246_bib46","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1053\/j.gastro.2018.01.005","article-title":"Accuracy of the enhanced liver fibrosis test vs FibroTest, elastography, and indirect markers in detection of advanced fibrosis in patients with alcohol-associated liver disease","volume":"154","author":"Thiele","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.07.246_bib47","article-title":"The performance of enhanced liver fibrosis (ELF) test for the staging of liver fibrosis: a meta-analysis","volume":"9","author":"Xie","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2022.07.246_bib48","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","article-title":"Transient elastography: a new noninvasive method for assessment of hepatic fibrosis","volume":"29","author":"Sandrin","year":"2003","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.jceh.2022.07.246_bib49","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1111\/j.1572-0241.2002.06038.x","article-title":"Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection","volume":"97","author":"Regev","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.07.246_bib50","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/HMER.S7394","article-title":"Liver stiffness: a novel parameter for the diagnosis of liver disease","volume":"2","author":"Mueller","year":"2010","journal-title":"Hepat Med"},{"key":"10.1016\/j.jceh.2022.07.246_bib51","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-110-9-685","article-title":"Methylprednisolone therapy in patients with severe alcohol-associated hepatitis: a randomized multicenter trial","volume":"110","author":"Carithers","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jceh.2022.07.246_bib52","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hep.20503","article-title":"MELD accurately predicts mortality in patients with alcohol-associated hepatitis","volume":"41","author":"Dunn","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.07.246_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-230X-2-2","article-title":"Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcohol-associated hepatitis","volume":"2","author":"Sheth","year":"2002","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jceh.2022.07.246_bib54","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jhep.2004.12.022","article-title":"MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcohol-associated hepatitis","volume":"42","author":"Srikureja","year":"2005","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.07.246_bib55","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/gut.2004.050781","article-title":"Analysis of factors predictive of mortality in alcohol-associated hepatitis and derivation and validation of the Glasgow alcohol-associated hepatitis score","volume":"54","author":"Forrest","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2022.07.246_bib56","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1111\/j.1572-0241.2008.02104.x","article-title":"A\u00a0new scoring system for prognostic stratification of patients with alcohol-associated hepatitis","volume":"103","author":"Dominguez","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.07.246_bib57","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1136\/gut.2006.099226","article-title":"The Glasgow alcohol-associated hepatitis score identifies patients who may benefit from corticosteroids","volume":"56","author":"Forrest","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2022.07.246_bib58","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jhep.2017.11.017","article-title":"Application of prognostic scores in the STOPAH trial: discriminant function is no longer the optimal scoring system in alcohol-associated hepatitis","volume":"68","author":"Forrest","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.07.246_bib59","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcohol-associated hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.07.246_bib60","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1053\/j.gastro.2015.04.044","article-title":"Combining data from liver disease scoring systems better predicts outcomes of patients with alcohol-associated hepatitis","volume":"149","author":"Louvet","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.07.246_bib61","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1053\/j.gastro.2016.12.019","article-title":"In patients with severe alcohol-associated hepatitis, prednisolone increases susceptibility to infection and infection-related mortality, and is associated with high circulating levels of bacterial DNA","volume":"152","author":"Vergis","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.07.246_bib62","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","article-title":"Prednisolone or pentoxifylline for alcohol-associated hepatitis","volume":"372","author":"Thursz","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2022.07.246_bib63","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1053\/j.gastro.2006.08.020","article-title":"Utility of a new model to diagnose an alcohol basis for steatohepatitis","volume":"131","author":"Dunn","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.07.246_bib64","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jhep.2006.02.010","article-title":"The diagnostic value of biomarkers (AshTest) for the prediction of alcohol-associated steato-hepatitis in patients with chronic alcohol-associated liver disease","volume":"44","author":"Thabut","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.07.246_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134302","article-title":"Validation of AshTest as a non-invasive alternative to transjugular liver biopsy in patients with suspected severe acute alcohol-associated hepatitis","volume":"10","author":"Rudler","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2022.07.246_bib66","doi-asserted-by":"crossref","unstructured":"Hanouneh IA, Zein NN, Cikach F, et\u00a0al. The breathprints in patients with liver disease identify novel breath biomarkers in alcohol-associated hepatitis. Clin Gastroenterol Hepatol. 2014;12:516-523.","DOI":"10.1016\/j.cgh.2013.08.048"},{"key":"10.1016\/j.jceh.2022.07.246_bib67","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.0954-6820.1955.tb18248.x","article-title":"Urinary excretion of trimethylamine and trimethylamine oxide following trimethylamine-administration to normals and to patients with liver disease","volume":"153","author":"Wranne","year":"1955","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.jceh.2022.07.246_bib68","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/hep.23009","article-title":"Endotoxemia and gut barrier dysfunction in alcohol-associated liver disease","volume":"50","author":"Rao","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.07.246_bib69","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1172\/JCI37762","article-title":"Toward unraveling the complexity of simple epithelial keratins in human disease","volume":"119","author":"Omary","year":"2009","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.jceh.2022.07.246_bib70","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1111\/j.1530-0277.2000.tb02087.x","article-title":"Increased serum tissue polypeptide specific antigen (TPS) in alcohol-associateds: a possible marker of alcohol-associated hepatitis","volume":"24","author":"Gonzalez-Quintela","year":"2000","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jceh.2022.07.246_bib71","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.alcohol.2006.01.003","article-title":"Serum cytokeratins in alcohol-associated liver disease: contrasting levels of cytokeratin-18 and cytokeratin-19","volume":"38","author":"Gonzalez-Quintela","year":"2006","journal-title":"Alcohol"},{"key":"10.1016\/j.jceh.2022.07.246_bib72","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1158\/0008-5472.CAN-03-2455","article-title":"Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18","volume":"64","author":"Kramer","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.jceh.2022.07.246_bib73","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.29080","article-title":"A\u00a0prospective study of the utility of plasma biomarkers to diagnose alcohol-associated hepatitis","volume":"66","author":"Bissonnette","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.07.246_bib74","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1016\/S0168-8278(20)30893-X","article-title":"Plasma protein glycomics combined with circulating fragments of cytokeratin-18 are reliable biomarkers to diagnose alcohol-associated hepatitis","volume":"73","author":"Xavier","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.07.246_bib75","first-page":"301","article-title":"Cell death and prognosis of mortality in alcohol-associated hepatitis patients using plasma keratin-18","volume":"17","author":"Woolbright","year":"2017","journal-title":"Gene Exp J Liver Res"},{"key":"10.1016\/j.jceh.2022.07.246_bib76","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.cgh.2019.11.050","article-title":"Keratin 18 is a diagnostic and prognostic factor for acute alcohol-associated hepatitis","volume":"18","author":"Vatsalya","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.07.246_bib77","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.14309\/ajg.0000000000000912","article-title":"In severe alcohol-associated hepatitis, serum cytokeratin-18 fragments are diagnostic, prognostic and theragnostic biomarkers","volume":"115","author":"Atkinson","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.07.246_bib78","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/hep.23050","article-title":"Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcohol-associated steatohepatitis: a multicenter validation study","volume":"50","author":"Feldstein","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.07.246_bib79","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1053\/j.gastro.2017.10.048","article-title":"Combination of gene expression signature and model for end-stage liver disease score predicts survival of patients with severe alcohol-associated hepatitis","volume":"154","author":"Tr\u00e9po","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.07.246_bib80","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/ng.3417","article-title":"A\u00a0genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis","volume":"47","author":"Buch","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.jceh.2022.07.246_bib81","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.1016\/S0168-8278(20)30873-4","article-title":"The role of PNPLA3, MBOAT7 and TM6SF2 during alcohol detoxification: different mechanisms of fibrosis and steatosis development","volume":"73","author":"Mueller","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.07.246_bib82","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/s41395-018-0041-8","article-title":"Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis","volume":"113","author":"Stickel","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.07.246_bib83","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/acer.12660","article-title":"Ethnic differences in presentation and severity of alcohol-associated liver disease","volume":"39","author":"Levy","year":"2015","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jceh.2022.07.246_bib84","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jhep.2017.01.018","article-title":"Homozygosity for rs738409: G in PNPLA3 is associated with increased mortality following an episode of severe alcohol-associated hepatitis","volume":"67","author":"Atkinson","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.07.246_bib85","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1079\/PNS2003327","article-title":"Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology","volume":"63","author":"Crabb","year":"2004","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.jceh.2022.07.246_bib86","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/cld.920","article-title":"Alcohol-associated liver disease: east versus west","volume":"16","author":"Charatcharoenwitthaya","year":"2021","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2022.07.246_bib87","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/S0168-8278(20)30663-2","article-title":"Genetic variation in HSD17B3 reduces the risk for developing severe alcohol-associated hepatitis","volume":"73","author":"Atkinson","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.07.246_bib88","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1056\/NEJMoa1712191","article-title":"A\u00a0protein-truncating HSD17B13 variant and protection from chronic liver disease","volume":"378","author":"Abul-Husn","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2022.07.246_bib89","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/498232","article-title":"MicroRNA signature in alcohol-associated liver disease","volume":"2012","author":"Bala","year":"2012","journal-title":"Int J Hepatol"},{"key":"10.1016\/j.jceh.2022.07.246_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms8321","article-title":"Exosome-delivered microRNAs modulate the inflammatory response to endotoxin","volume":"6","author":"Alexander","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jceh.2022.07.246_bib91","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12967-015-0623-9","article-title":"Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcohol-associated hepatitis","volume":"13","author":"Momen-Heravi","year":"2015","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.jceh.2022.07.246_bib92","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/hep.25614","article-title":"Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcohol-associated hepatitis","volume":"55","author":"Sancho-Bru","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.07.246_bib93","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1136\/gutjnl-2015-311314","article-title":"Integrative microRNA profiling in alcohol-associated hepatitis reveals a role for microRNA-182 in liver injury and inflammation","volume":"65","author":"Blaya","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2022.07.246_bib94","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1530-0277.2007.00584.x","article-title":"Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcohol-associated liver disease","volume":"32","author":"Tang","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jceh.2022.07.246_bib95","doi-asserted-by":"crossref","first-page":"9991","DOI":"10.1038\/srep09991","article-title":"Exosomes derived from alcohol-treated hepatocytes horizontally transfer liver specific miRNA-122 and sensitize monocytes to LPS","volume":"5","author":"Momen-Heravi","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2022.07.246_bib96","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.4049\/jimmunol.0901084","article-title":"Ethanol-induced expression of ET-1 and ET-BR in liver sinusoidal endothelial cells and human endothelial cells involves hypoxia-inducible factor-1\u03b1 and microRNA-199","volume":"183","author":"Yeligar","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jceh.2022.07.246_bib97","article-title":"Biological properties of extracellular vesicles and their physiological functions","volume":"4","author":"Y\u00e1\u00f1ez-M\u00f3","year":"2015","journal-title":"J\u00a0Extracell Vesicles"},{"key":"10.1016\/j.jceh.2022.07.246_bib98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep10721","article-title":"Biodistribution and function of extracellular miRNA-155 in mice","volume":"5","author":"Bala","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2022.07.246_bib99","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.nano.2014.03.014","article-title":"Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages","volume":"10","author":"Momen-Heravi","year":"2014","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"10.1016\/j.jceh.2022.07.246_bib100","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1074\/jbc.M110.145870","article-title":"Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor \u03b1 (TNF\u03b1) production via increased mRNA half-life in alcohol-associated liver disease","volume":"286","author":"Bala","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jceh.2022.07.246_bib101","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3389\/fimmu.2014.00370","article-title":"Extracellular vesicles as therapeutic tools in cardiovascular diseases","volume":"5","author":"Fleury","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.jceh.2022.07.246_bib102","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrgastro.2017.71","article-title":"Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets","volume":"14","author":"Szabo","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.07.246_bib103","first-page":"1","article-title":"Transcriptomic profiling identifies novel hepatic and intestinal genes following chronic plus binge ethanol feeding in mice","author":"Jiang","year":"2020","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2022.07.246_bib104","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2015-310585","article-title":"Intestinal microbiota contributes to individual susceptibility to alcohol-associated liver disease","volume":"65","author":"Llopis","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2022.07.246_bib105","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","article-title":"Bacteriophage targeting of gut bacterium attenuates alcohol-associated liver disease","volume":"575","author":"Duan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jceh.2022.07.246_bib106","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.cgh.2016.10.029","article-title":"Healthy donor fecal microbiota transplantation in steroid-ineligible severe alcohol-associated hepatitis: a pilot study","volume":"15","author":"Philips","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.07.246_bib107","doi-asserted-by":"crossref","unstructured":"Jiang L, Lang S, Duan Y, et al. Intestinal virome in patients with alcohol-associated hepatitis. Hepatology. 2020 Dec;72:2182-2196. doi: 10.1002\/hep.31459. Epub 2020 Oct 10. PMID: 32654263; PMCID: PMC8159727.","DOI":"10.1002\/hep.31459"},{"key":"10.1016\/j.jceh.2022.07.246_bib108","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/hep.30832","article-title":"Intestinal fungal dysbiosis and systemic immune response to fungi in patients with alcohol-associated hepatitis","volume":"71","author":"Lang","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.07.246_bib109","doi-asserted-by":"crossref","first-page":"G497","DOI":"10.1152\/ajpgi.00171.2004","article-title":"Recent advances in alcohol-associated liver disease IV. Dysregulated cytokine metabolism in alcohol-associated liver disease","volume":"287","author":"McClain","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jceh.2022.07.246_bib110","series-title":"Paper presented at: Seminars in Liver Disease","article-title":"Cytokines in alcohol-associated liver disease","author":"McClain","year":"1999"},{"key":"10.1016\/j.jceh.2022.07.246_bib111","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hep.20206","article-title":"A\u00a0double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcohol-associated hepatitis","volume":"39","author":"Naveau","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.07.246_bib112","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1572-0241.2004.04034.x","article-title":"A\u00a0pilot study of the safety and tolerability of etanercept in patients with alcohol-associated hepatitis","volume":"99","author":"Menon","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.07.246_bib113","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/S0168-8278(20)30658-9","article-title":"Lipidomics profiling reveals a distinct pattern of selective lipid depletion in the circulation and liver tissue in patients with progressive alcohol-associated liver fibrosis: a biopsy-controlled study in 400 people","volume":"73","author":"Thiele","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.07.246_bib114","first-page":"S181","article-title":"Alterations and role of bioactive lipid metabolites (oxylipins) in human and experimental ALD: associations with disease severity","volume":"73","author":"Warner","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.07.246_bib115","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1016\/S0168-8278(20)30859-X","article-title":"A\u00a0novel lymphocyte proliferation assay accurately predicts 90-day survival in severe alcohol-associated hepatitis patients","volume":"73","author":"Yates","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.07.246_bib116","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.cgh.2017.11.022","article-title":"Molecular ellipticity of circulating albumin-bilirubin complex associates with mortality in patients with severe alcohol-associated hepatitis","volume":"16","author":"Das","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.07.246_bib117","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jhep.2018.03.031","article-title":"Dysregulation of serum bile acids and FGF19 in alcohol-associated hepatitis","volume":"69","author":"Brandl","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.07.246_bib118","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1016\/S0168-8278(20)30882-5","article-title":"The development and severity of alcohol-associated hepatitis is associated with decreased intestinal microbiome-derived secondary bile acid isoursodeoxycholic acid","volume":"73","author":"Muthiah","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.07.246_bib119","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1111\/j.1478-3231.2008.01789.x","article-title":"Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C","volume":"28","author":"Cal\u00e8s","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2022.07.246_bib120","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/MEG.0000000000000409","article-title":"Diagnostic usefulness of FibroMeter VCTE for hepatic fibrosis in patients with nonalcohol-associated fatty liver disease","volume":"27","author":"Dincses","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.07.246_bib121","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0399-8320(08)73992-7","article-title":"FibroMeters: a family of blood tests for liver fibrosis","volume":"32","author":"Cal\u00e8s","year":"2008","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.jceh.2022.07.246_bib122","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1016\/S0168-8278(20)30862-X","article-title":"Fibroblast growth factor 21 response in a preclinical model of alcohol induced acute-on-chronic liver injury","volume":"73","author":"Grigorios","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.07.246_bib123","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1016\/S0168-8278(20)30868-0","article-title":"Temporal change in the plasma metabolome profile is indicative of outcome in severe alcohol-associated hepatitis","volume":"73","author":"Maras","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.07.246_bib124","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/hep.31535","article-title":"Genome-wide association study and meta-analysis on alcohol-related liver cirrhosis identifies novel genetic risk factors","volume":"73","author":"Schwantes-An","year":"2021","journal-title":"Hepatology"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S097368832200411X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S097368832200411X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:07:39Z","timestamp":1760854059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S097368832200411X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":109,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S097368832200411X"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2022.07.246","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging Biomarkers in Alcohol-associated Hepatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2022.07.246","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}